AlphAIalphai — Financial news for AI agents
tickerreport.comJUN 44 min read$AVR

Stock Traders Purchase Large Volume of Anteris Technologies Global Call Options (NASDAQ:AVR)

Anteris Technologies Global (NASDAQ:AVR) saw unusually heavy options activity on Thursday, with investors buying 7,578 call options versus an average 329 (+2,203%). Shares rose to $9.61. The company reported May 12 quarterly EPS of -$0.28 (vs -$0.27 expected) on revenue of $0.49M (vs $0.77M).

Original reporting
tickerreport.com
Published Jun 4, 2026, 4:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 4, 2026, 4:48 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Stock Traders Purchase Large Volume of Anteris Technologies Global Call Options (NASDAQ:AVR) — source image
Source · tickerreport.com
Decision brief

The 30-second read

$AVRBullishMed
01

Why it matters

The main actionable signal is the outsized call-option volume spike, which can attract momentum traders even when fundamentals are weak.

02

Market read

Traders may treat the options-flow spike as a short-term catalyst for volatility and upside attempts, but fundamentals remain a headwind.

03

What to watch

The article lacks details on strike/expiry, dealer positioning, and whether the flow is concentrated—key for assessing whether this is a sustained bullish bet.

Relevance 7/10Novelty 6/10Timing: Thursday’s options flow (published same day) following the May 12 earnings print.

Background

AVR is a medical-device company; it last reported earnings May 12 with EPS and revenue below consensus.

Company-level read

Ticker impact

$AVRBullishMedium confidence
Context

AVR saw unusually large call-option buying (7,578 contracts, +2,203% vs average), signaling fresh bullish positioning into/after recent earnings.

Expected impact

Near-term volatility higher; upside-biased flow could support a bounce toward recent highs if follow-through occurs.

Evidence & confidence

The article provides a concrete, time-stamped options-flow spike and also notes the latest earnings miss, creating a clear setup for sentiment-driven price action.

Market effects

Sector

Limited direct read-across; medical-device microcaps can react sharply to options-flow signals.

Regional

No specific regional linkage beyond US small-cap sentiment.

Global

Minimal; company-specific derivatives activity with no stated global catalyst.

Counterpoint

What could challenge this read

Call buying may reflect hedging or speculative lottery tickets rather than a durable fundamental re-rating.

Key entities

  • company
    Anteris Technologies Global Corp.

    Subject of the unusual call-option buying and the recent earnings/revenue miss referenced in the article.

  • market
    AVR options market

    7,578 call options bought, +2,203% vs average, indicating abnormal demand.

Read at source← All news

Related articles

JUN 4
$AVRMed

Anteris Technologies Global (NASDAQ:AVR) Shares Up 12.6% – Should You Buy?

Anteris Technologies Global (NASDAQ:AVR) shares rose 12.6% to $10.0750 on Thursday, after closing at $8.95; the stock traded between $9.71 and $10.0750. Volume was 176,960 shares, down 84% vs. average. Analysts cited mixed views: Barclays raised its target to $18 (overweight), while Wall Street Zen moved to hold; consensus target is $16. In its May 12 earnings, the company reported -$0.28 EPS vs -$0.27 expected on $0.49M revenue vs $0.77M.

tickerreport.com5 min
AUG 9
$SMCIMed

Super Micro Computer Landed $60 Billion in Orders Last Quarter, but Trades at Just $30

Super Micro Computer (SMCI) said it booked over $60B in new orders in its fiscal Q4 ended June 30, lifting backlog to a record. It guided FY2026 revenue near the low end of $11B to $12.5B and gross margins at 15% to 17%. The company also plans $7B equity financing for AI server orders, noting some orders may not be firm and citing an independent review tied to export control issues.

fool.com6 min
AUG 9
$CSCOMed

Cisco Stock Is Finally Pricing In A New Growth Story

Cisco raised full-year revenue and EPS guidance on May 13, 2026, citing AI infrastructure demand. Management expects about $9 billion in FY2026 AI orders from hyperscalers and cited 5 hyperscaler design wins in Q3. Cisco shares rose about 20% since, with product orders up 19% YoY excluding hyperscaler growth. Options imply 41% IV ahead of the next catalyst.

yahoo.com7 min
AUG 9
$RMDMed

Off Into Weekend, As Early Work Undone

ResMed (ASX:RMD) fell 8.29% on Friday and is 3.09% lower for the week after a strong run. The company reported a solid Q4, with FY26 revenue up 10% to $5.7b, gross Q4 margin 62.3%, FY EPS up 17% to $11.17, and a 10% dividend increase to $0.66. Morgan Stanley downgraded to Equal Weight and cut its price target, citing cooling growth and Philips’ potential US return in 2027.

thebull.com.au6 min